Skip to main content

Pharmacokinetics and Pharmacodynamics in Nursing

This guide explains the core principles of pharmacokinetics (how the body affects a drug) and pharmacodynamics (how a drug affects the body) from a nursing perspective. It covers drug absorption, distribution, metabolism, elimination, therapeutic ranges, drug interactions, and strategies for promoting patient adherence

Save this reading to your study set

Sign up free

In the complex field of pharmacology, nurses serve as the primary line of defense for patient safety. While physicians often prescribe medications, it is the nurse who monitors how those medications interact with the unique physiological environment of the patient. To provide safe and effective care, a nurse must master two fundamental concepts: pharmacokinetics, which describes how the body acts upon a drug, and pharmacodynamics, which describes how the drug acts upon the body. Understanding these processes allows nurses to anticipate side effects, prevent toxicity, and ensure that therapeutic goals are met through precise assessment and patient education.

Understanding Pharmacokinetics: The Body's Journey with a Drug

Pharmacokinetics is the study of the movement of a drug through the body. This process is typically broken down into four stages: absorption, distribution, biotransformation (metabolism), and elimination.

Drug Absorption and Distribution

Drug absorption is the process by which a drug moves from its site of administration into the bloodstream. Several factors can influence this rate. For example, the presence of food can significantly alter absorption. Nurses must be particularly careful with enteric-coated tablets; these are designed to dissolve in the small intestine rather than the stomach. Advise patients to avoid high-fat foods before taking these medications, as fat can decrease the absorption rate.

Once absorbed, the drug is distributed throughout the body. A critical factor in distribution is protein binding. Many drugs travel through the bloodstream bound to plasma proteins (like albumin). Only the "free" or unbound portion of the drug is pharmacologically active and able to reach its target tissue. If a patient has protein-energy malnutrition, they may have lower levels of albumin, leading to more "free" drug in the system and an increased risk of toxicity.

Keep reading for free.

Create an account to finish this reading and make it part of your study routine.

Continue reading free

Already have an account? Log in

Updated

Study it your way.

Import this reading into your study set to get started with another study mode.

Make it your own.

Keep this reading in a new study set, or add it to one you already use.